Obestatin as a regulator of adipocyte metabolism and adipogenesis

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 9, 2011, Pages 1927-1940

  Gurriarán Rodríguez, Uxía ^a,b   Al Massadi, Omar ^a,b   Roca Rivada, Arturo ^a,b   Crujeiras, Ana Belén ^a,b   Gallego, Rosalía ^c   Pardo, Maria ^a,b   Seoane, Luisa Maria ^a,b   Pazos, Yolanda ^a,b   Casanueva, Felipe F ^a,b,c   Camiña, Jesús P ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adipocyte metabolism; Adipogenesis; Akt

Indexed keywords

ADENYLATE KINASE; FATTY ACID TRANSPORTER; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; PROTEIN KINASE B; SLC2A1 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; AUTOCRINE EFFECT; CELL MEMBRANE; CELL STRAIN 3T3; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; MALE; METABOLISM; MOUSE; PARACRINE SIGNALING; PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADENYLATE KINASE; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ANIMALS; AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CELL MEMBRANE; ENZYME ACTIVATION; FATTY ACID TRANSPORT PROTEINS; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; MALE; MICE; PARACRINE COMMUNICATION; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 80052151208     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01192.x     Document Type: Article

References (52)

1. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007; 131: 242-56.
2. Park KW, Halperin DS, Tontonoz P. Before they were fat: adipocyte progenitors. Cell Metab. 2007; 8: 454-7.
3. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008; 77: 289-312.
4. Wang P, Mariman E, Renes J, et al. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol. 2008; 216: 3-13.
5. Wells T. Ghrelin-defender of fat. Prog Lipid Res. 2009; 48: 257-74.
6. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000; 407: 908-13.
7. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001; 50: 2540-7.
8. Tschöp M, Flora DB, Mayer JP, et al. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes Res. 2002; 10: 991-9.
9. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006; 116: 1983-93.
10. Davies JS, Kotokorpi P, Eccles SR, et al. Ghrelin induces abdominal obesityviaGHS-R-dependent lipid retention. Mol Endocrinol. 2009; 23: 914-24.
11. Choi K, Roh SG, Hong YH, et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology. 2003; 144: 754-9.
12. Thompson NM, Gill DA, Davies R, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directlyin vivoby a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004; 145: 234-42.
13. Rodríguez A, Gómez-Ambrosi J, Catalán V, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond). 2009; 33: 541-52.
14. Tsubone T, Masaki T, Katsuragi I, et al. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept. 2005; 130: 97-103.
15. Muccioli G, Pons N, Ghè C, et al. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytesviaa non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol. 2004; 498: 27-35.
16. Zhu X, Cao Y, Voogd K, et al. On the processing of proghrelin to ghrelin. J Biol Chem. 2006; 281: 38867-70.
17. Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005; 310: 996-9.
18. Seoane LM, Al-Massadi O, Pazos Y, et al. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest. 2006; 29: RC13-5.
19. Chartrel N, Alvear-Perez R, Leprince J, et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science. 2007; 315: 766.
20. Nogueiras R, Pfluger P, Tovar S, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology. 2007; 148: 21-6.
21. Zhang JV, Jahr H, Luo CW, et al. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol. 2008; 22: 1464-75.
22. Pazos Y, Alvarez CJ, Camiña JP, et al. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors. 2007; 25: 373-81.
23. Alvarez CJ, Lodeiro M, Theodoropoulou M, et al. Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocr Relat Cancer. 2009; 16: 599-611.
24. Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes. 2008; 57: 967-79.
25. Egerod KL, Holst B, Petersen PS, et al. GPR39 splice variantsversusantisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue. Mol Endocrinol. 2007; 21: 1685-8.
26. Catalán V, Gómez-Ambrosi J, Rotellar F, et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2007; 66: 598-601.
27. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007; 129: 1261-74.
28. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009; 89: 1025-78.
29. Zizzari P, Longchamps R, Epelbaum J, et al. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology. 2007; 148: 1648-53.
30. Xu J, Liao K. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem. 2004; 279: 35914-22.
31. Chen WS, Xu PZ, Gottlob K, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 2001; 15: 2203-8.
32. Cho H, Thorvaldsen JL, Chu Q, et al. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem. 2001; 276: 38349-52.
33. Garofalo RS, Orena SJ, Rafidi K, et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest. 2003; 112: 197-208.
34. Berggreen C, Gormand A, Omar B, et al. Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab. 2009; 296: E635-46.
35. Kane S, Sano H, Liu SC, et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem. 2002; 277: 22115-8.
36. Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem. 2003; 278:14599-602.
37. Eguez L, Lee A, Chavez JA, et al. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2005; 2: 263-72.
38. Larance M, Ramm G, Stöckli J, et al. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem. 2005; 280: 37803-13.
39. Zaid H, Antonescu CN, Randhawa VK, et al. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J. 2008; 413: 201-15.
40. Rayasam GV, Tulasi VK, Sodhi R, et al. Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol. 2009; 156: 885-98.
41. Sundqvist A, Bengoechea-Alonso MT, Ye X, et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 2005; 1: 379-91.
42. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 2006; 3: 393-402.
43. Kim JE, Chen J. Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes. 2004; 53: 2748-56.
44. Dann SG, Selvaraj A, Thomas G. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med. 2007; 13: 252-9.
45. Um SH, Frigerio F, Watanabe M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature. 2004; 431: 200-5.
46. Zhang HH, Huang J, Düvel K, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One. 2009; 4: e6189.
47. Munday MR. Regulation of mammalian acetyl-CoA carboxylase. Biochem Soc Trans. 2002; 30: 1059-64.
48. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006; 7: 885-96.
49. Kim MS, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol. 2004; 18: 2291-301.
50. Vicennati V, Genghini S, De Iasio R, et al. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol. 2007; 157: 295-301.
51. Huda MS, Durham BH, Wong SP, et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes. 2008; 32: 129-35.
52. Zamrazilová H, Hainer V, Sedlácková D, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res. 2008; 57:S49-55.